Healthcare - Biotechnology - NASDAQ - US
$ 0.8125
-9.72 %
$ 3.01 M
Market Cap
-0.06
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
20.76%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Bio-Path Holdings, Inc.
BPTH has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart BPTH
EBIT FORECAST
EBIT Forecast Chart BPTH
NET INCOME FORECAST
Net Income Chart BPTH